Zurcher Kantonalbank (Zurich Cantonalbank) Tyra Biosciences, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 9,047 shares of TYRA stock, worth $82,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,047Holding current value
$82,327% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$96.8 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$37.7 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$37.1 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$36.9 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$36.9 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $382M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...